SOLARA.BO

Solara Active Pharma Sciences Limited SOLARA.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SOLARA.BO ALEMBICLTD.NS MOREPENLAB.BO MOREPENLAB.NS INDOCO.BO INDOCO.NS SMSPHARMA.BO SMSPHARMA.NS IOLCP.BO IOLCP.NS
6M 15.10 % -2.65 % -8.72 % -8.83 % 18.91 % 18.35 % 33.16 % 33.21 % 40.97 % 40.57 %
YTD -14.44 % -22.58 % -37.96 % -37.93 % -13.26 % -13.37 % 12.11 % 12.63 % 15.83 % 15.63 %
1Y -27.19 % -19.49 % -40.11 % -40.11 % -13.79 % -13.85 % -6.45 % -6.38 % 17.18 % 16.95 %
3Y 57.36 % 52.73 % 82.45 % 82.71 % -14.43 % -14.56 % 224.87 % 227.04 % 34.22 % 33.24 %
5Y -43.65 % 5.95 % 89.48 % 89.40 % 14.77 % 13.80 % 221.44 % 221.04 % -29.69 % -29.89 %
10Y 137.88 % 175.70 % 188.39 % 188.27 % -15.30 % -15.28 % 271.76 % 271.74 % 493.34 % 492.47 %
From the beginning 137.88 % 2 451.24 % -67.22 % 141.17 % 445.36 % 447.46 % 757.69 % 753.81 % 10 065.25 % 758.75 %

Dividend

Solara Active Pharma Sciences Limited

Alembic Limited

Morepen Laboratories Limited

Morepen Laboratories Limited

Indoco Remedies Limited

Indoco Remedies Limited

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited